US FDA gives green light for thyroid cancer drug lenvatinib Lenvatinib will be available in the United States by the end of February 2015 after its approval was fast-tracked by the FDA.…
US healthcare groups recommend ways of tackling ongoing drug shortages Recommendations for addressing ongoing shortages of essential medicines have been made by a group of US healthcare organisations.…
Breast cancer drug palbociclib gets expedited approval in United States The US Food and Drug Administration has approved palbociclib (Ibrance; Pfizer) for advanced (metastatic) breast cancer under its accelerated approval programme.…
Insomnia drug suvorexant launched in the United States Suvorexant (Belsomra), a first-in-class orexin receptor antagonist drug, is now available on prescription in the United States for adults with insomnia.…
New antibiotics for skin infections get seal of approval from European Medicines Agency Three new antibiotics to treat serious skin infections have been recommended for approval by the European Medicines Agency.…
Sanofi and Mannkind launch inhaled insulin in the United StatesSanofi and Mannkind Corporation have launched Afrezza, an inhaled insulin approved to control high blood sugar in adults with type 1 and type 2 diabetes.…
Study questions FDA warning over adverse cognitive effects of statins In 25 placebo-controlled trials involving nearly 47,000 patients, adverse cognitive outcomes attributable to statins were rarely reported, researchers found.…
Drug shortages: it’s time for Europe to act Unlike the United States, Europe has no plan for coordinated action to mitigate drug shortages.…
Searching social networks to detect adverse reactions Regulators and pharmaceutical companies are monitoring social media posts for potential adverse drug reaction signals.…
Gold standard guidance on injectable drugs ‘Handbook on injectable drugs, 18th edition’, editor-in-chief Gerald K McEvoy.…
